iBio (IBIO)
(Delayed Data from AMEX)
$1.97 USD
-0.09 (-4.37%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.97 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IBIO 1.97 -0.09(-4.37%)
Will IBIO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for IBIO
iBio Updates CEO Employment Terms and Compensation Package
iBio initiated with bullish view at Brookline
Twelve option delistings on June 24th
Ibio Resolves Debt with Property Sale to Texas A&M
iBio Closes Sale of Manufacturing Facility in Texas